SCHEMBL2881496

SCHEMBL2881496

CO[C@@H]([C@H](O)[C@@H](C)O)[C@@H](C=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31387070 1.00
SCHEMBL7154707 1.00
SCHEMBL11361209 1.00
SCHEMBL11389350 1.00
SCHEMBL11395005 1.00
SCHEMBL10401701 0.86
SCHEMBL2743440 0.86
SCHEMBL21586158 0.86
SCHEMBL8718277 0.86
SCHEMBL2168395 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807800-B2 Erythromycins and process for their preparation BIOTICA TECHNOLOGY LIMITED (GB) 2010-10-05 US claimed
US-20080044860-A1 Polyketides and Their Synthesis PFIZER, INC. 2008-02-21 US claimed
WO-2025150052-A1 TARGETED DELIVERY OF DRUG CONJUGATES TO SCHWANN CELLS AND TREATMENT METHODS IN SCHWANN CELL-RELATED DISEASES Potentia Ltd. (IL) 2025-07-17 WO disclosed
EP-4525932-A1 TARGETED DELIVERY TO SCHWANN CELLS AND TREATMENT METHODS IN SCHWANN CELL-RELATED DISEASES Potentia Ltd (IL) 2025-03-26 EP disclosed
WO-2024013563-A1 TARGETED DELIVERY TO SCHWANN CELLS AND TREATMENT METHODS IN SCHWANN CELL-RELATED DISEASES POTENTIA THERAPEUTICS LTD (IL) 2024-01-18 WO disclosed
US-7846452-B2 Potent immunostimulatory extracts from microalgae THE UNIVERSITY OF MISSISSIPPI (US) 2010-12-07 US disclosed
US-20100003275-A1 Immunostimulatory Composition comprising Lipoprotein in Microalgae Extract THE UNIVERSITY OF MISSISSIPPI (US) 2010-01-07 US disclosed
EP-2064232-A2 IMMUNOSTIMULATORY COMPOSITION COMPRISING LIPOPROTEIN IN MICROALGAE EXTRACT University of Mississippi (US) 2009-06-03 EP disclosed
WO-2008031092-A9 IMMUNOSTIMULATORY COMPOSITION COMPRISING LIPOPROTEIN IN MICROALGAE EXTRACT UNIV MISSISSIPPI (US) 2008-07-31 WO disclosed
WO-2008031092-A2 IMMUNOSTIMULATORY COMPOSITION COMPRISING LIPOPROTEIN IN MICROALGAE EXTRACT UNIVERSITY OF MISSISSIPPI (US) 2008-03-13 WO disclosed
US-20080044860-A1 Polyketides and Their Synthesis PFIZER, INC. 2008-02-21 US disclosed
US-20060024328-A1 exhibit extremely potent immunostimulatory activity; extraction of these immunostimulatory agents is dependent on the solvent used and the extraction temperature; preparations are potentially useful as a botanical or pharmaceutical preparation to improve immune function THE UNIVERSITY OF MISSISSIPPI 2006-02-02 US disclosed
EP-1301191-B1 POTENT IMMUNOSTIMULANTS FROM MICROALGAE UNIV MISSISSIPPI (US) 2005-12-07 EP disclosed
EP-1301191-A4 POTENT IMMUNOSTIMULANTS FROM MICROALGAE UNIV MISSISSIPPI (US) 2004-02-25 EP disclosed
WO-2003098184-A2 METHOD FOR IDENTIFYING MODULATORS OF SULFOTRANSFERASE ACTIVITY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-11-27 WO disclosed
EP-1301191-A1 POTENT IMMUNOSTIMULANTS FROM MICROALGAE The University of Mississippi (US) 2003-04-16 EP disclosed
WO-2002004000-A1 POTENT IMMUNOSTIMULANTS FROM MICROALGAE THE UNIVERSITY OF MISSISSIPPI (US) 2002-01-17 WO disclosed
US-4377636-A HETEROPOLYSACCHARIDE, PSEUDOMONAS MERCK & CO., INC. (US) 1983-03-22 US disclosed
US-4326052-A THICKENERS MERCK & CO., INC. (US) 1982-04-20 US disclosed
US-4326053-A HETEROPOLYSACCHARIDES, THICKENERS MERCK & CO., INC. (US) 1982-04-20 US disclosed